Intestinal Pseudo-Obstruction: Clinical Trials

3 trials for Intestinal Pseudo-Obstruction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 21Completed 1

Follow Intestinal Pseudo-Obstruction: new trials by email Literature Review of Intestinal Pseudo-Obstruction trials Research Report on Intestinal Pseudo-Obstruction

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)
Eluxadoline, Placebo - Irritable Bowel Syndrome
Phase 3CompletedFuriex Pharmaceuticals, Inc11462012-05-292018-07-30
The Effects of Gum Chewing on Bowel Function Recovery Following Cesarean Section
Gum chewing - Paralytic Ileus
Phase 2 / Phase 3CompletedChiang Mai University1002010-05-012011-06-28
Outcome of Palliative Management of Malignant Large Bowel Obstruction w/Colorectal Stents or Surgery
Luminal stents, Minimally Invasive Surgical Bowel Diversion - Large Bowel Obstruction
Phase 3CompletedMemorial Sloan Kettering Cancer Center1802002-12-012007-12-10

Narrower conditions

Colonic Pseudo-Obstruction (2)  ·  Colonic Diseases (1)  ·  Colonic Diseases, Functional (1)  ·  Diarrhea (1)  ·  Digestive System Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Intestinal Diseases (1)  ·  Irritable Bowel Syndrome (1)  ·  Signs and Symptoms, Digestive (1)

Broader conditions

Ileus (3)  ·  Intestinal Obstruction (3)  ·  Digestive System Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Colonic Diseases (1)  ·  Colonic Diseases, Functional (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Chewing Gum (1)  ·  eluxadoline (1)

Sponsors

Chiang Mai University (1)  ·  Furiex Pharmaceuticals, Inc (1)  ·  Memorial Sloan Kettering Cancer Center (1)

Countries

United States (2)  ·  Canada (1)  ·  Puerto Rico (1)  ·  Thailand (1)  ·  United Kingdom (1)

Top investigators

Hans Gerdes, M.D. (1)  ·  Kittipat Charoenkwan, MD (1)

Results publications

PMID 26789872, PMID 28167156